| |
| Trade Name | LT-CAGE LUMBAR TAPERED FUSION DEVICE |
| Classification Name | intervertebral fusion device with bone graft, lumbar |
| Generic Name | intervertebral body fusion device |
| Regulation Number | 888.3080 |
| Applicant | MEDTRONIC SOFAMOR DANEK USA, INC. |
| PMA Number | P970015 |
| Supplement Number | S029 |
| Date Received | 09/22/2004 |
| Decision Date | 07/22/2005 |
| Product Code | |
| Advisory Committee |
Orthopedic |
| Supplement Type | real-time process |
| Supplement Reason | change design/components/specifications - specifications |
| Expedited Review Granted? | No |
| Combination Product |
No
|
Approval Order Statement Approval for the addition of the 14mm x 26mm cage titanium lt-cage lumbar tapered fusion device. The device remains indicated for spinal fusion procedures in skeletally mature patients with degenerative disc disease (ddd) at one level from l2-s1. Ddd is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These ddd patients may also have up to grade i spondylolisthesis or retrolisthesis at the involved level. Lt-cage devices are to be used with autogenous bone graft and implanted via a laparoscopic or an open anterior approach. Patients receiving the lt-cage lumbar tapered fusion device should have had at least six months of nonoperative treatment prior to treatment with the lt-cage device. |